RT Journal Article
SR Electronic
T1 Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 spread in Belgium by means of a compartmental, age-stratified, extended SEIQRD model and public mobility data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.17.20156034
DO 10.1101/2020.07.17.20156034
A1 Alleman, Tijs W.
A1 Vergeynst, Jenna
A1 De Visscher, Lander
A1 Rollier, Michiel
A1 Illana, Daniel
A1 Torfs, Elena
A1 Nopens, Ingmar
A1 Baetens, Jan M.
YR 2021
UL http://medrxiv.org/content/early/2021/03/29/2020.07.17.20156034.abstract
AB We present a compartmental, age-stratified, nation-level, extended SEIQRD model to model SARS-CoV-2 spread in Belgium. We demonstrate the robustness of the calibration procedure by calibrating the model using incrementally larger datasets and dissect the model results by computing the effective reproduction number at home, in workplaces, in schools and during leisure activities. We find that schools are a major contributor to SARS-CoV-2 spread, with the potential to increase the basic reproduction number from Re = 0.66 ± 0.04 to Re = 1.09 ± 0.05 under lockdown measures. The model accounts for the main characteristics of SARS-CoV-2 transmission and COVID-19 disease and features a detailed representation of hospitals with parameters derived from two Ghent (Belgium) hospitals. Social contact during the pandemic is modelled by scaling pre-pandemic contact matrices with publically available mobility data from Google and with effectivity parameters inferred from hospitalization data. The combination of the deterministic epidemiological model, which incorporates rigid a-priori knowledge on disease dynamics, and the calibrated effectivity parameters in the social contact model allow us to combine the ease of long-term extrapolation and scenario-analysis of compartmental models with the flexibility of a data-driven model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Ghent University Special Research Fund. The funding source played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data is publically available on the BIOMATH GitHub repo (https://github.com/UGentBiomath/COVID19-Model/). https://github.com/UGentBiomath/COVID19-Model